Rising Regulatory And Geopolitical Risks Will Undermine API Profits

AN

AnalystLowTarget

AnalystLowTarget

Not Invested

Community Contributor

Published

12 Aug 25

Updated

25 Jan 26

Views

7

n/a

n/a

AnalystLowTarget's Fair Value

n/a

1Y

-32.8%

7D

-1.9%

Loading

1Y

-32.8%

7D

-1.9%

You can edit this narrative until Jan 26 3:05 PM. Then, changes will post as Updates.

Author's Valuation

€27.6% overvalued

AnalystLowTarget Fair Value

Shared on 25 Jan 26

EAPI: Execution Risks And Lower Outlook Will Shape Future Return Profile

Narrative update Analysts have trimmed their price target on Euroapi by €0.50 to €2.00, citing updated assumptions on revenue growth, profit margins and forward P/E that keep their stance cautious on the shares. Analyst Commentary Recent research has reinforced a cautious stance on Euroapi, with bearish analysts trimming their price targets to €2.00.

Shared on 10 Jan 26

EAPI: Lower Profitability Assumptions And New Partnership Will Shape Future Returns

Analysts have trimmed their price target on Euroapi to €2 from €2.50, citing softer assumptions around revenue growth, profit margins and a higher future P/E multiple as the key drivers of the reset. Analyst Commentary Bearish analysts are signalling a cautious stance on Euroapi by aligning around a lower price target of €2, narrowed from €2.50.

Shared on 19 Dec 25

Fair value Decreased 20%

EAPI: Higher Discount Rate Will Outweigh Benefits From New Corticosteroid Partnership

Analysts have slightly reduced their Euroapi price target, reflecting a modest reassessment of fair value. This adjustment accounts for a higher discount rate, even as long term profit margin assumptions edge up and revenue declines appear marginally less severe.

AnalystLowTarget Fair Value

€2

7.6% overvalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

2.02%

Pharma revenue growth rate

0.78%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

6.18%

Calculation

€28.37m

Earnings '29

x

8.02x

PE Ratio '29

=

€227.45m

Market Cap '29

€227.45m

Market Cap '29

/

95.21m

No. shares '29

=

€2.39

Share Price '29

€2.39 Share Price '29

Discounted to 2026 @ 6.18% p.a.

=

€2.00

Fair Value '26